Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: Enhanced gene expression and synthesis of skeletal muscle glucose transporter 4

Hypertension Research

Volumn 20, Issue 4, 1997, Pages 279-286

  Katayama, Shigehiro ^a   Inaba, Munemichi ^a   Maruno, Yoshiko ^a   Morita, Toshisuke ^a   Awata, Takuya ^a   Oka, Yoshitomo ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Glucose intolerance; Glucose transporter 4; Insulin resistance; Spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN SYNTHESIS; RAT; SKELETAL MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CAPTOPRIL; CELL MEMBRANE; FASTING; GENE EXPRESSION; GLUCOSE INTOLERANCE; HEART RATE; HYPERTENSION; INSULIN; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE, SKELETAL; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; SYSTOLE; TIME FACTORS;

EID: 0031469772     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.279     Document Type: Article

References (38)

1. DeFronzo RA: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-368.
2. Granner DK, O'Brien RM: Molecular physiology and genetics of NIDDM: importance of metabolic staging. Diabetes Care 1992; 15: 369-395.
3. Lucus CP, Estigarribia JA, Darga LL, Reaven GM: Insulin and blood pressure in obesity. Hypertension 1985; 7: 702-706.
4. Singer P, Godicke W, Voigt S, Hajdu I, Weiss M: Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 1985; 7: 182-186.
5. Modan M, Halkin H, Almong S: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
6. Ferrannini E, Buzzigoli G, Bonadona R, et al: Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
7. Shen D-C, Shieh S-M, Fuh MM-T, Wu D-A, Chen Y-DI, Reaven GM: Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580-583.
8. Yamori Y, Ohta K, Ohtake M, Nara Y, Horie R, Ooshima A: Glucose metabolism in spontaneously hypertensive rats. Jpn Heart J 1978; 19: 559-560.
9. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988; 37: 303-305.
10. Reaven GM, Chang H, Hoffman BB, Azhar S: Resistance to insulin-stimulated glucose uptake in adipocyte isolated from spontaneously hypertensive rats. Diabetes 1989; 38: 1155-1160.
11. Buchanan TS, Sipos GF, Madrilejo N, Liu C, Campese VM: Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol 1992; 262: E14-E19.
12. Katayama S, Abe M, Kashiwabara H, Kosegawa I, Ishii J: Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. CS-045 does not lower blood pressure despite improvement of insulin resistance. Hypertension 1994; 23 (part 2): 1071-1074.
13. Katayama S, Omoto A, Maruno Y, et al: Hyperreninemia due to increased renal renin synthesis in BioBreeding Worcester rats. Hypertension 1990; 15: 854-860.
14. Chomozynski P, Sacchi N: Single step method of RNA isolation by acid guanidine thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Lin J-L, Asano T, Shibasaki Y, et al: Altered expression of glucose transport isoforms with aging in rats: selective decrease in Glut4 in the fat tissue and skeletal muscle. Diabetologia 1991; 34: 477-482.
16. Cleveland DW, Lopata MA, MacDonal RJ, Cowan NJ, Rutter WJ, Kirschner MW: Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell 1980; 20: 95-105.
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 1970; 227: 680-685.
18. Samani NJ, Swales JD, Jeffreys AJ, et al: DNA fingerprinting of spontaneously hypertensive and Wistar-Kyoto rats: implication for hypertension research. J Hypertens 1989; 7: 809-816.
19. Gould GW, Bell GI: Facilitative glucose transporters: an expanding family. Trends Biochem Sci 1990; 15: 18-23.
20. Mueckler M: Family of glucose transporter genes. Diabetes 1990; 39: 6-11.
21. Berger J, Biswas C, Vicario PP, Strout VH, Saperstein R, Pilch PF: Decreased expression of insulin-responsive glucose transporter in diabetes and fasting. Nature (Lond) 1989; 340: 70-72.
22. Kahn BB, Charron MJ, Lodish HF, Cushman SW, Filer JS: Differential regulation of two glucose transporters in adipose cells from diabetic and insulin-stimulated diabetic rats. J Clin Invest 1989; 84: 404-411.
23. Martin P, Rebuffe-Servie S, Smith U, Bjorntorp P: Glucose uptake in human adipose tissue. Metabolism 1987; 36: 1154-1160.
24. Garvey Wt, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP: Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 1991: 87: 1072-1081.
25. Dohm GL, Elton CW, Friedman JE, et al: Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol 1991; 260: E459-E463.
26. Pederson O, Bak JF, Anderson PH, et al: Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990; 39: 865-870.
27. Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J: Expression of insulin-regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990; 33: 625-627.
28. Davidson MB: The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979; 28: 688-705.
29. Fink RI, Kolterman OG, Griffin J, Olefsky JM: Mechanisms of insulin resistance in aging. J Clin Invest 1983; 71: 1523-1535.
30. Rowe JW, Minaker KL, Palotta JA, Flier JS: Characterization of the insulin resistance of aging. J Clin Invest 1983; 71: 1581-1587.
31. Goodman MN, Dluz SM, McElaney MA, Belur E, Runderman NB: Glucose uptake and insuln sensitivity in rat muscle: changes during 3-96 weeks of age. Am J Physiol 1983; 244: E93-E100.
32. Olefsky JM, Reaven GM: Effect of age and obesity on insulin binding in isolated adipocytes. Endocrinology 1975; 96: 1486-1496.
33. Studelska DR, Campbell C, Pang S, Rodnick KJ, James DE: Developmental expression of insulin-regulatable glucose transporter GLUT-4. Am J Physiol 1992; 263: E102-E106.
34. Barnard RJ, Lawani LO, Martin DA, Youngren JF, Singh R, Scheck SH: Effects of maturation and aging on the skeletal muscle glucose transport system. Am J Physiol 1992; 262: E619-E626.
35. Kern M, Dolan PL, Mazzeo RS, Wells JA, Dohm GL: Effects of aging and exercise on GLUT-4 glucose transporter in muscle. Am J Physiol 1992; 263: E362-E367.
36. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-873.
37. Kodama J, Katayama S, Tanaka K, Itabashi A, Kawazu S, Ishii J: Effect of captopril on glucose concentration: possible role of augmented postprandial forearm blood flow. Diabetes Care 1990; 13: 1109-1111.
38. Chen S, Kashiwabara H, Kosegawa I, Ishii J, Katayama S: Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. Clin Exp Hypertension 1996; 18: 625-636.